Abstract
A collaborative study including centres in the United Kingdom, Australia, and New Zealand was instituted in 1970 to determine the incidence of cancer in patients treated for at least three months with azathioprine, cyclophosphamide, or chlorambucil. Follow-up of 3823 renal transplant recipients showed an almost 60-fold increase of non-Hodgkin's lymphoma together with an excess of squamous-cell skin cancer and mesenchymal tumours. A series of 1349 patients without transplants showed an excess of the same tumours, though to a less extent. These preliminary findings provide no clear evidence that immunosuppressive drugs produce the increased risk of most of the common cancers that might be expected from the simplest interpretation of impaired "immunosurveillance."
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- BURNET M. SOMATIC MUTATION AND CHRONIC DISEASE. Br Med J. 1965 Feb 6;1(5431):338–342. doi: 10.1136/bmj.1.5431.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bengtsson U., Angervall L., Ekman H., Lehmann L. Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol. 1968;2(3):145–150. doi: 10.3109/00365596809135358. [DOI] [PubMed] [Google Scholar]
- Doak P. B., Montgomerie J. Z., North J. D., Smith F. Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy. Br Med J. 1968 Dec 21;4(5633):746–748. doi: 10.1136/bmj.4.5633.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Doll R., Kinlen L. Immunosurveillance and cancer: epidemiological evidence. Br Med J. 1970 Nov 14;4(5732):420–422. doi: 10.1136/bmj.4.5732.420. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gregory M. C., Hughes J. T. Intracranial reticulum cell sarcoma associated with immunoglobulin A deficiency. J Neurol Neurosurg Psychiatry. 1973 Oct;36(5):769–776. doi: 10.1136/jnnp.36.5.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Isomäki H. A., Hakulinen T., Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis. 1978;31(11):691–696. doi: 10.1016/0021-9681(78)90071-1. [DOI] [PubMed] [Google Scholar]
- Lipsmeyer E. A. Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression. Arthritis Rheum. 1972 Mar-Apr;15(2):183–186. doi: 10.1002/art.1780150207. [DOI] [PubMed] [Google Scholar]
- Penn I., Hammond W., Brettschneider L., Starzl T. E. Malignant lymphomas in transplantation patients. Transplant Proc. 1969 Mar;1(1):106–112. [PMC free article] [PubMed] [Google Scholar]
- Ulrich J., Wüthrich R. Multiple sclerosis: reticulum cell sarcoma of the nervous system in a patient treated with immunosuppressive drugs. Eur Neurol. 1974;12(2):65–78. doi: 10.1159/000114606. [DOI] [PubMed] [Google Scholar]
- Walder B. K., Robertson M. R., Jeremy D. Skin cancer and immunosuppression. Lancet. 1971 Dec 11;2(7737):1282–1283. doi: 10.1016/s0140-6736(71)90602-7. [DOI] [PubMed] [Google Scholar]
- Wall R. L., Clausen K. P. Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med. 1975 Aug 7;293(6):271–273. doi: 10.1056/NEJM197508072930604. [DOI] [PubMed] [Google Scholar]